or Try an Advanced Search...

    Technical Analysis for IGC - India Globalization Capital Inc.

    Grade Last Price % Change Price Change
    F 0.34 3.36% 0.01
    IGC closed down 2.86 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical IGC trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 3.36%
    Below Lower BB Weakness 3.36%
    Lower Bollinger Band Touch Weakness 3.36%
    Oversold Stochastic Weakness 3.36%
    NR7 Range Contraction 0.41%
    Lower Bollinger Band Walk Weakness 0.41%
    Inside Day Range Contraction 0.41%
    Below Lower BB Weakness 0.41%
    Lower Bollinger Band Touch Weakness 0.41%
    Oversold Stochastic Weakness 0.41%
    Older End-of-Day Signals for IGC ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 2 hours ago
    Rose Above Lower Bollinger Band about 4 hours ago
    Up 2% about 4 hours ago
    Up 1% about 4 hours ago
    Fell Below Lower Bollinger Band 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IGC Chart by TradingView
    Basic chart:

    Profile

    India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pain Alzheimer's Disease Cannabis Parkinson's Disease Disorders Dog Medicinal Plants Psychiatric Diagnosis Epilepsy Herbalism Cannabis Smoking Medical Cannabis Nausea

    Is IGC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 IGC Pharma GAAP EPS of -$0.02 beats by $0.01, revenue of $0.41M beats by $0.21M
    Nov 14 IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
    Nov 6 IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
    Oct 17 IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
    Oct 3 IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
    Sep 18 IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
    Sep 4 IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease
    Aug 26 IGC Announces Results of its 2024 Annual Stockholders Meeting
    Aug 22 IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
    Aug 20 IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist
    See more IGC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.9099
    52 Week Low 0.2501
    Average Volume 419,311
    200-Day Moving Average 0.41
    50-Day Moving Average 0.37
    20-Day Moving Average 0.38
    10-Day Moving Average 0.36
    Average True Range 0.02
    RSI (14) 33.77
    ADX 30.68
    +DI 11.34
    -DI 19.20
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.40
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.34
    Percent B (%b) -0.03
    BandWidth 21.45
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0058
    Fundamentals Value
    Market Cap 21.24 Million
    Num Shares 63.7 Million
    EPS -0.20
    Price-to-Earnings (P/E) Ratio -1.67
    Price-to-Sales 14.24
    Price-to-Book 1.38
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.36
    Resistance 3 (R3) 0.36 0.36 0.36
    Resistance 2 (R2) 0.36 0.35 0.36 0.36
    Resistance 1 (R1) 0.35 0.34 0.34 0.34 0.35
    Pivot Point 0.34 0.34 0.34 0.34 0.34
    Support 1 (S1) 0.33 0.33 0.32 0.32 0.31
    Support 2 (S2) 0.32 0.33 0.32 0.31
    Support 3 (S3) 0.31 0.32 0.31
    Support 4 (S4) 0.30